In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week on a subdued note. At the time of writing, the benchmark index is down 0.1% to 7,050.8 points.
Four ASX shares that are not letting that hold them back are listed below. Here's why they are charging higher:
Doctor Care Anywhere Group PLC (ASX: DOC)
The Doctor Care Anywhere share price is up almost 4% to $1.07. This follows the release of the telehealth company's first quarter update. For the three months ended 31 March, Doctor Care Anywhere reported a 16.5% increase in unaudited underlying revenue to 4.4 million pounds (A$6.87 million). This was driven partly by a 14.7% increase in sign-ups to the platform to 500,000 and a 21.9% increase in consultations delivered to 90,500.
Next Science Ltd (ASX: NXS)
The Next Science share price has rocketed 25% higher to $1.78. Investors have been fighting to get hold of the medical device company's shares after the US FDA approved its XPerience No Rinse Antimicrobial Solution. The XPerience product is inserted into a surgical site, which is then closed, to fight infection for up to several hours afterwards. Management believes the product can be used in every open surgery.
NIB Holdings Limited (ASX: NHF)
The NIB share price is up 10% to $5.91 after providing guidance for FY 2021. According to its trading update, the private health insurer has been performing positively during the second half. As a result, it expects to report underlying operating profit of $200 million to $225 million in FY 2021. This will be a big lift from the first half, when it posted underlying operating profit of $86.9 million.
Talga Group Ltd (ASX: TLG)
The Talga share price has jumped 25% to $1.71. This appears to be a delayed reaction to the company providing an update on its electric vehicle anode (EVA) qualification plant last week. According to the release, designs for the plant have been finalised and engineering work is progressing well. Talga has now placed orders for materials and equipment and hopes to commence its EVA plant's installation in the fourth quarter of 2021.
